Association of Systemic Inflammatory Response Index and Pan-Immune-Inflammation-Value with Long-Term Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention

References

• Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361–2371. PMID: 36368511. doi:10.1016/j.jacc.2022.11.005
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al.; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177. PMID: 28886621. doi:10.1093/eurheartj/ehx393
   PubMed Web of Science ®Google Scholar
• Vogel B, Claessen BE, Arnold SV, et al. ST-segment elevation myocardial infarction. Nat Rev Dis Primers. 2019;5(1):39. PMID: 31171787. doi:10.1038/s41572-019-0090-3
   PubMed Web of Science ®Google Scholar
• Khera S, Kolte D, Gupta T, et al. Temporal trends and sex differences in revascularization and outcomes of ST-segment elevation myocardial infarction in younger adults in the United States. J Am Coll Cardiol. 2015;66(18):1961–1972. PMID: 26515998. doi:10.1016/j.jacc.2015.08.865
   PubMed Web of Science ®Google Scholar
• Desai MM, Stauffer BD, Feringa HH, Schreiner GC. Statistical models and patient predictors of readmission for acute myocardial infarction: a systematic review. Circ Cardiovasc Qual Outcomes. 2009;2(5):500–507. PMID: 20031883. doi:10.1161/CIRCOUTCOMES.108.832949
   PubMed Web of Science ®Google Scholar
• Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47(8 Suppl):C7–12. PMID: 16631513. doi:10.1016/j.jacc.2005.09.068
   PubMed Web of Science ®Google Scholar
• Pietilä KO, Harmoinen AP, Jokiniitty J, Pasternack AI. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J. 1996;17(9):1345–1349. PMID: 8880019. doi:10.1093/oxfordjournals.eurheartj.a015068
   PubMed Web of Science ®Google Scholar
• Kumar V, Prabhu SD, Bansal SS. CD4+ T-lymphocytes exhibit biphasic kinetics post-myocardial infarction. Front Cardiovasc Med. 2022;9:992653. PMID: 36093172; PMCID: PMC9452745. doi:10.3389/fcvm.2022.992653
   PubMedGoogle Scholar
• Kumar V, Rosenzweig R, Asalla S, Nehra S, Prabhu SD, Bansal SS. TNFR1 contributes to activation-induced cell death of pathological CD4+ T lymphocytes during ischemic heart failure. JACC Basic Transl Sci. 2022;7(10):1038–1049. PMID: 36337927; PMCID: PMC9626895. doi:10.1016/j.jacbts.2022.05.005
   PubMedGoogle Scholar
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–1695. PMID: 15843671. doi:10.1056/NEJMra043430
   PubMed Web of Science ®Google Scholar
• Balta S, Ozturk C. The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2015;26(7):680–681. PMID: 25549287. doi:10.3109/09537104.2014.979340
   PubMed Web of Science ®Google Scholar
• Öcal L, Keskin M, Cerşit S, et al. Systemic immune-inflammation index predicts in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction. Coron Artery Dis. 2022;33(4):251–260. PMID: 35044330. doi:10.1097/MCA.0000000000001117
   PubMed Web of Science ®Google Scholar
• Han K, Shi D, Yang L, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Ann Med. 2022;54(1):1667–1677. PMID: 35695557; PMCID: PMC9225721. doi:10.1080/07853890.2022.2083671
   PubMed Web of Science ®Google Scholar
• Murat B, Murat S, Ozgeyik M, Bilgin M. Comparison of pan-immune-inflammation value with other inflammation markers of long-term survival after ST-segment elevation myocardial infarction. Eur J Clin Invest. 2023;53(1):e13872. PMID: 36097823. doi:10.1111/eci.13872
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Executive group on behalf of the joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) task force for the universal definition of myocardial infarction. fourth universal definition of myocardial infarction. Circulation. 2018;138(20):e618–e651. PMID: 30571511. doi:10.1161/CIR.0000000000000617
   PubMed Web of Science ®Google Scholar
• Verheggen PW, de Maat MP, Cats VM, et al. Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function. Eur Heart J. 1999;20(8):567–574. PMID: 10337541. doi:10.1053/euhj.1998.1312
   PubMed Web of Science ®Google Scholar
• Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009;54(4):281–292. PMID: 19608025. doi:10.1016/j.jacc.2009.03.054
   PubMed Web of Science ®Google Scholar
• Liu Y, Ye T, Chen L, et al. Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease. Coron Artery Dis. 2021;32(8):715–720. PMID: 33826540. doi:10.1097/MCA.0000000000001037
   PubMed Web of Science ®Google Scholar
• Núñez J, Núñez E, Bodí V, et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol. 2008;101(6):747–752. PMID: 18328833. doi:10.1016/j.amjcard.2007.11.004
   PubMed Web of Science ®Google Scholar
• Ozcan Cetin EH, Cetin MS, Aras D, et al. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in ST-segment elevation myocardial infarction. Angiology. 2016;67(4):336–345. PMID: 26101368. doi:10.1177/0003319715591751
   PubMed Web of Science ®Google Scholar
• Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014;35(42):2950–2959. PMID: 25139896. doi:10.1093/eurheartj/ehu299
   PubMed Web of Science ®Google Scholar
• Tsai TH, Chua S, Hussein H, et al. Outcomes of patients with Killip class III acute myocardial infarction after primary percutaneous coronary intervention. Crit Care Med. 2011;39(3):436–442. PMID: 21242801. doi:10.1097/CCM.0b013e318206ccc3
   PubMed Web of Science ®Google Scholar
• Ndrepepa G, Tiroch K, Keta D, et al. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction. Circ Cardiovasc Interv. 2010;3(1):27–33. PMID: 20118156. doi:10.1161/CIRCINTERVENTIONS.109.896225
   PubMed Web of Science ®Google Scholar
• Morishima I, Sone T, Mokuno S, et al. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J. 1995;130(2):239–243. PMID: 7631601. doi:10.1016/0002-8703(95)90434-4
   PubMed Web of Science ®Google Scholar
• Xu Y, He H, Zang Y, et al. Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study. Clin Rheumatol. 2022;41(7):1989–2000. PMID: 35266094. doi:10.1007/s10067-022-06122-1
   PubMed Web of Science ®Google Scholar
• Geng Y, Zhu D, Wu C, et al. A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. Int Immunopharmacol. 2018;65:503–510. PMID: 30408627. doi:10.1016/j.intimp.2018.10.002
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xing Z, Zhou K, Jiang S. The predictive role of Systemic Inflammation Response Index (SIRI) in the prognosis of stroke patients. Clin Interv Aging. 2021;16:1997–2007. PMID: 34880606; PMCID: PMC8645951. doi:10.2147/CIA.S339221
   PubMed Web of Science ®Google Scholar
• Jin Z, Wu Q, Chen S, et al. The associations of two novel inflammation indexes, SII and SIRI with the risks for cardiovascular diseases and all-cause mortality: a ten-year follow-up study in 85,154 individuals. J Inflamm Res. 2021;14:131–140. PMID: 33500649; PMCID: PMC7822090. doi:10.2147/JIR.S283835
   PubMed Web of Science ®Google Scholar
• Sen N, Afsar B, Ozcan F, et al. The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Atherosclerosis. 2013;228(1):203–210. PMID: 23489347. doi:10.1016/j.atherosclerosis.2013.02.017
   PubMed Web of Science ®Google Scholar
• Song FH, Zheng YY, Tang JN, et al. A correlation between monocyte to lymphocyte ratio and long-term prognosis in patients with coronary artery disease after PCI. Clin Appl Thromb Hemost. 2021;27:1076029621999717. PMID: 33749340; PMCID: PMC7989235. doi:10.1177/1076029621999717
   Web of Science ®Google Scholar
• Dragu R, Huri S, Zukermann R, et al. Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis. 2008;196(1):405–412. PMID: 17173924. doi:10.1016/j.atherosclerosis.2006.11.022
   PubMed Web of Science ®Google Scholar
• Guasti L, Dentali F, Castiglioni L, et al. Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. A systematic review on more than 34,000 subjects. Thromb Haemost. 2011;106(4):591–599. PMID: 21866299. doi:10.1160/TH11-02-0096
   PubMed Web of Science ®Google Scholar
• Major AS, Fazio S, Linton MF. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol. 2002;22(11):1892–1898. PMID: 12426221. doi:10.1161/01.atv.0000039169.47943.ee
   PubMed Web of Science ®Google Scholar
• Blum A, Sclarovsky S, Rehavia E, Shohat B. Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction. Am Heart J. 1994;127(5):1226–1230. PMID: 8172050. doi:10.1016/0002-8703(94)90040-x
   PubMed Web of Science ®Google Scholar
• Ommen SR, Gibbons RJ, Hodge DO, Thomson SP. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol. 1997;79(6):812–814. PMID: 9070569. doi:10.1016/s0002-9149(96)00878-8
   PubMed Web of Science ®Google Scholar
• Gisterå A, Hansson GK. The immunology of atherosclerosis. Nat Rev Nephrol. 2017;13(6):368–380. PMID: 28392564. doi:10.1038/nrneph.2017.51
   PubMed Web of Science ®Google Scholar
• Lindau A, Härdtner C, Hergeth SP, et al. Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression. Basic Res Cardiol. 2016;111(2):20. EPMID: 26891724; PMCID: PMC4759214. doi:10.1007/s00395-016-0535-8
   PubMed Web of Science ®Google Scholar
• Gratchev A, Sobenin I, Orekhov A, Kzhyshkowska J. Monocytes as a diagnostic marker of cardiovascular diseases. Immunobiology. 2012;217(5):476–482. PMID: 22325375. doi:10.1016/j.imbio.2012.01.008
   PubMed Web of Science ®Google Scholar
• Li G, Hao Y, Wang C, Wang S, Xiong Y, Zhao X. Association between neutrophil-to-lymphocyte ratio/lymphocyte-to-monocyte ratio and in-hospital clinical outcomes in ischemic stroke treated with intravenous thrombolysis. J Inflamm Res. 2022;15:5567–5578. PMID: 36185640; PMCID: PMC9518842. doi:10.2147/JIR.S382876
   PubMed Web of Science ®Google Scholar
• Ibrahim H, Schutt RC, Hannawi B, DeLao T, Barker CM, Kleiman NS. Association of immature platelets with adverse cardiovascular outcomes. J Am Coll Cardiol. 2014;64(20):2122–2129. PMID: 25457402. doi:10.1016/j.jacc.2014.06.1210
   PubMed Web of Science ®Google Scholar